-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HitfB+YWINfR/QBOkYPLvf9T9axGyRIBaQ+eNbRxWp+8OhpB5YUKGqcytr6SjJe3 w+0UHOeVnbD1NMOq6gAhpg== 0001490109-10-000001.txt : 20100423 0001490109-10-000001.hdr.sgml : 20100423 20100423123437 ACCESSION NUMBER: 0001490109-10-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20100423 DATE AS OF CHANGE: 20100423 EFFECTIVENESS DATE: 20100423 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Carmot Therapeutics Inc. CENTRAL INDEX KEY: 0001490109 IRS NUMBER: 261872684 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-141033 FILM NUMBER: 10766576 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 510-828-0102 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D 1 primary_doc.xml X0704 D LIVE 0001490109 Carmot Therapeutics Inc. 409 ILLINOIS STREET SAN FRANCISCO CA CALIFORNIA 94158 510-828-0102 DELAWARE None None Corporation true 2008 Daniel A. Erlanson 409 Illinois Street San Francisco CA CALIFORNIA 94158 Executive Officer Director Stig K. Hansen 409 Illinois Street San Francisco CA CALIFORNIA 94158 Executive Officer Director Tim Kutzkey 1700 Owens Street Suite 595 San Francisco CA CALIFORNIA 94158 Director Magnus Persson 1700 Owens Street Suite 595 San Francisco CA CALIFORNIA 94158 Director Biotechnology Decline to Disclose 06 false 2010-04-07 false true false 0 1549999 1549999 0 false 2 0 0 0 false Carmot Therapeutics Inc. /s/ Stig K. Hansen Stig K. Hansen Chief Executive Officer 2010-04-22 -----END PRIVACY-ENHANCED MESSAGE-----